$25.39
0.220.87%
In chiusura: -
$25.34
-0.05-0.20%
After hour: Jul 3, 3:47 PM EDT
ARK Genomic Revolution ETF (BATS: ARKG)
Ticker | Name | Share % | |
---|---|---|---|
TWST | Twist Bioscience Corp. | 6.98% | |
CDNA | Caredx | 3.97% | |
SM | Crispr Therapeutics Ag | 8.52% | |
RXRX | Recursion Pharmaceuticals, Inc. | 5.45% | |
IONS | Ionis Pharmaceuticals Inc | 4.88% | |
NTLA | Intellia Therapeutics | 4.74% | |
BEAM | Beam Therapeutics Inc | 4.09% | |
SDGR | Schrodinger, Inc. | 4.73% | |
ADPT | Adaptive Biotechnologies Corporation | 4.76% | |
TXG | 10X Genomics Inc | 3.61% | |
TEM | Tempus Pe | 9.57% | |
NTRA | Natera Inc | 6.12% | |
GH | Guardant Health Inc. | 6.11% | |
VCYT | Veracyte Inc (vcyt) | 3.57% | |
PSNL | Personalis Inc Com | 3.67% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
ARKG segue uno stile di investimento Small Cap Growth.
Le principali posizioni di ARKG includono: TWST (6.98%), CDNA (3.97%), SM (8.52%), RXRX (5.45%), IONS (4.88%). Queste rappresentano le posizioni più grandi nel portafoglio dell'ETF.
I dati del volume medio giornaliero per ARKG non sono attualmente disponibili.